Gene Panel Testing for Inherited Cancer Risk

Restricted access

Next-generation sequencing technologies have ushered in the capability to assess multiple genes in parallel for genetic alterations that may contribute to inherited risk for cancers in families. Thus, gene panel testing is now an option in the setting of genetic counseling and testing for cancer risk. This article describes the many gene panel testing options clinically available to assess inherited cancer susceptibility, the potential advantages and challenges associated with various types of panels, clinical scenarios in which gene panels may be particularly useful in cancer risk assessment, and testing and counseling considerations. Given the potential issues for patients and their families, gene panel testing for inherited cancer risk is recommended to be offered in conjunction or consultation with an experienced cancer genetic specialist, such as a certified genetic counselor or geneticist, as an integral part of the testing process.

Correspondence: Veda N. Giri, MD, Thomas Jefferson University, Benjamin Franklin Building, 834 Chestnut Street, Suite 314, Philadelphia, PA 19107. E-mail: Veda.Giri@jefferson.edu
  • 1.

    RizzoJMBuckMJ. Key principles and clinical applications of “next-generation” DNA sequencing. Cancer Prev Res (Phila)2012;5:887900.

    • Search Google Scholar
    • Export Citation
  • 2.

    National Cancer Institute. Cancer Genetics Overview (PDQ). Available at: http://www.cancer.gov/cancertopics/pdq/genetics/overview/healthprofessional/allpages#5. Accessed May 4 2014.

    • Search Google Scholar
    • Export Citation
  • 3.

    MacConaillLE. Existing and emerging technologies for tumor genomic profiling. J Clin Oncol2013;31:18151824.

  • 4.

    LinnarssonS. Recent advances in DNA sequencing methods: general principles of sample preparation. Exp Cell Res2010;316:13391343.

  • 5.

    EastonDFDeffenbaughAMPrussD. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet2007;81:873883.

    • Search Google Scholar
    • Export Citation
  • 6.

    ThompsonBAGoldgarDEPatersonC. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Hum Mutat2013;34:200209.

    • Search Google Scholar
    • Export Citation
  • 7.

    DomchekSMBradburyAGarberJE. Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?J Clin Oncol2013;31:12671270.

    • Search Google Scholar
    • Export Citation
  • 8.

    WalshTCasadeiSLeeMK. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A2011;108:1803218037.

    • Search Google Scholar
    • Export Citation
  • 9.

    ChurpekJWalshTZhengY. Inherited mutations in breast cancer genes in African American breast cancer patients revealed by targeted genomic capture and next-generation sequencing [abstract]. J Clin Oncol2013;31(Suppl):Abstract CRA1501.

    • Search Google Scholar
    • Export Citation
  • 10.

    YurgelunMAllenBKaldateR. Germline mutations identified by a 25-gene panel in patients undergoing Lynch syndrome testing. Presented at the Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC) Annual Meeting; October 7-8, 2013; Anaheim, California.

    • Search Google Scholar
    • Export Citation
  • 11.

    NorquistBMPenningtonKPAgnewKJ. Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing. Gynecol Oncol2013;128:483487.

    • Search Google Scholar
    • Export Citation
  • 12.

    ThompsonDDuedalSKirnerJ. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst2005;97:813822.

  • 13.

    McWilliamsRRPetersenGMRabeKG. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer2010;116:203209.

    • Search Google Scholar
    • Export Citation
  • 14.

    RebbeckTRMitraNDomchekSM. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Res2009;69:58015810.

    • Search Google Scholar
    • Export Citation
  • 15.

    DomchekSMFriebelTMSingerCF. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA2010;304:967975.

    • Search Google Scholar
    • Export Citation
  • 16.

    GroverSStoffelEMMercadoRC. Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol2009;27:39813986.

    • Search Google Scholar
    • Export Citation
  • 17.

    CulverJOBrinkerhoffCDClagueJ. Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress. Clin Genet2013;84:464472.

    • Search Google Scholar
    • Export Citation
  • 18.

    HirakiSRinellaESSchnabelF. Cancer risk assessment using genetic panel testing: considerations for clinical application. J Genet Couns2014;23:604617.

    • Search Google Scholar
    • Export Citation
  • 19.

    HallMJReidJEBurbidgeLA. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breastovarian cancer. Cancer2009;115:22222233.

    • Search Google Scholar
    • Export Citation
  • 20.

    FacioFMLeeKO’DanielJM. A genetic counselor’s guide to using next-generation sequencing in clinical practice. J Genet Couns2014;23:455462.

    • Search Google Scholar
    • Export Citation
  • 21.

    FrostCJVenneVCunninghamDGerritsen-McKaneR. Decision making with uncertain information: learning from women in a high risk breast cancer clinic. J Genet Couns2004;13:221236.

    • Search Google Scholar
    • Export Citation
  • 22.

    FitzgeraldRCHardwickRHuntsmanD. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet2010;47:436444.

    • Search Google Scholar
    • Export Citation
  • 23.

    PyeritzRE. The coming explosion in genetic testing—is there a duty to recontact?N Engl J Med2011;365:13671369.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 444 444 46
PDF Downloads 127 127 12
EPUB Downloads 0 0 0